Heather K Vincent1, Steven Z George, Amanda N Seay, Kevin R Vincent, Robert W Hurley. 1. 1Department of Orthopaedics and Rehabilitation, Interdisciplinary Center for Musculoskeletal Training and Research, University of Florida, Gainesville, FL; 2Department of Physical Therapy and Center for Pain Research and Behavioral Health, University of Florida, Gainesville, FL; and 3Departments of Anesthesiology, Psychiatry, Orthopaedics, and Neurology, University of Florida, Gainesville, FL.
Abstract
PURPOSE: The purpose of this study was to compare the effects of two different resistance exercise protocols on self-reported disability, fear avoidance beliefs, pain catastrophizing, and back pain symptoms in obese, older adults with low back pain (LBP). METHODS:Obese adults (n = 49, 60-85 yr) with chronic LBP were randomized into a total body resistance exercise intervention (TOTRX), lumbar extensor exercise intervention (LEXT), or a control group (CON). Main outcomes included perceived disability (Oswestry Disability Index, Roland Morris Disability Questionnaire). Psychosocial measures included the Fear Avoidance Beliefs survey, Tampa Scale of Kinesiophobia, and Pain Catastrophizing Scale. LBP severity was measured during three functional tasks: walking, stair climbing, and chair rise using an 11-point numerical pain rating scale. RESULTS: The TOTRX group had greater reductions in self-reported disability scores due to back pain (Oswestry Disability Index, Roland Morris Disability Questionnaire) compared with those in the LEXT (P < 0.05). The Pain Catastrophizing Scale scores decreased in the TOTRX group compared with that in the CON group by month 4 (64.3% vs 4.8%, P < 0.05). Pain severity during chair rise activity and walking was decreased in both the LEXT and TOTRX groups relative to the CON group. CONCLUSIONS: Greater reductions in perceived disability due to LBP can be achieved with TOTRX compared with those achieved with LEXT. Pain catastrophizing and pain severity decreased most with TOTRX. The positive change in psychological outlook may assist obese, older adults with chronic back pain in reconsidering the harmfulness of the pain and facilitate regular participation in other exercise programs.
RCT Entities:
PURPOSE: The purpose of this study was to compare the effects of two different resistance exercise protocols on self-reported disability, fear avoidance beliefs, pain catastrophizing, and back pain symptoms in obese, older adults with low back pain (LBP). METHODS:Obese adults (n = 49, 60-85 yr) with chronic LBP were randomized into a total body resistance exercise intervention (TOTRX), lumbar extensor exercise intervention (LEXT), or a control group (CON). Main outcomes included perceived disability (Oswestry Disability Index, Roland Morris Disability Questionnaire). Psychosocial measures included the Fear Avoidance Beliefs survey, Tampa Scale of Kinesiophobia, and Pain Catastrophizing Scale. LBP severity was measured during three functional tasks: walking, stair climbing, and chair rise using an 11-point numerical pain rating scale. RESULTS: The TOTRX group had greater reductions in self-reported disability scores due to back pain (Oswestry Disability Index, Roland Morris Disability Questionnaire) compared with those in the LEXT (P < 0.05). The Pain Catastrophizing Scale scores decreased in the TOTRX group compared with that in the CON group by month 4 (64.3% vs 4.8%, P < 0.05). Pain severity during chair rise activity and walking was decreased in both the LEXT and TOTRX groups relative to the CON group. CONCLUSIONS: Greater reductions in perceived disability due to LBP can be achieved with TOTRX compared with those achieved with LEXT. Pain catastrophizing and pain severity decreased most with TOTRX. The positive change in psychological outlook may assist obese, older adults with chronic back pain in reconsidering the harmfulness of the pain and facilitate regular participation in other exercise programs.
Authors: Jeffrey Roelofs; Judith K Sluiter; Monique H W Frings-Dresen; Mariëlle Goossens; Pascal Thibault; Katja Boersma; Johan W S Vlaeyen Journal: Pain Date: 2007-02-20 Impact factor: 6.961
Authors: Kathryn H Schmitz; Peter J Hannan; Steven D Stovitz; Cathy J Bryan; Meghan Warren; Michael D Jensen Journal: Am J Clin Nutr Date: 2007-09 Impact factor: 7.045
Authors: Rebecca A Shelby; Tamara J Somers; Francis J Keefe; Jennifer J Pells; Kim E Dixon; James A Blumenthal Journal: J Pain Date: 2008-07-07 Impact factor: 5.820
Authors: Beverly E Thorn; Laura B Pence; L Charles Ward; Gary Kilgo; Kristi L Clements; Tony H Cross; Amber M Davis; Patricia W Tsui Journal: J Pain Date: 2007-08-09 Impact factor: 5.820
Authors: Robert H Dworkin; Dennis C Turk; Kathleen W Wyrwich; Dorcas Beaton; Charles S Cleeland; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Robert D Kerns; Deborah N Ader; Nancy Brandenburg; Laurie B Burke; David Cella; Julie Chandler; Penny Cowan; Rozalina Dimitrova; Raymond Dionne; Sharon Hertz; Alejandro R Jadad; Nathaniel P Katz; Henrik Kehlet; Lynn D Kramer; Donald C Manning; Cynthia McCormick; Michael P McDermott; Henry J McQuay; Sanjay Patel; Linda Porter; Steve Quessy; Bob A Rappaport; Christine Rauschkolb; Dennis A Revicki; Margaret Rothman; Kenneth E Schmader; Brett R Stacey; Joseph W Stauffer; Thorsten von Stein; Richard E White; James Witter; Stojan Zavisic Journal: J Pain Date: 2007-12-11 Impact factor: 5.820
Authors: Asimina Lazaridou; Marc O Martel; Marise Cornelius; Olivia Franceschelli; Claudia Campbell; Michael Smith; Jennifer A Haythornthwaite; John R Wright; Robert R Edwards Journal: Pain Med Date: 2019-05-01 Impact factor: 3.750
Authors: Joshua Hanel; Patrick J Owen; Steffen Held; Scott D Tagliaferri; Clint T Miller; Lars Donath; Daniel L Belavy Journal: Sports Med Date: 2020-12 Impact factor: 11.136
Authors: Neil Welch; Kieran Moran; Joseph Antony; Chris Richter; Brendan Marshall; Joe Coyle; Eanna Falvey; Andrew Franklyn-Miller Journal: BMJ Open Sport Exerc Med Date: 2015-11-09
Authors: Andrew J Kittelson; Sarah J Schmiege; Katrina Maluf; Steven Z George; Jennifer E Stevens-Lapsley Journal: Pain Med Date: 2021-03-18 Impact factor: 3.750